 |
Genocea Biosciences
Last updated: January 20, 2024
CEO Chip Clark
Country: USA | Funding: $520.6M (+)
Website: http://www.genocea.com/
We’ve created a pipeline of novel vaccine and immunotherapy programs that stimulate the T cell arm of the immune system, which is increasingly recognized as critical to generating protective immune responses against a wide array of diseases.
Website: http://www.genocea.com/
We’ve created a pipeline of novel vaccine and immunotherapy programs that stimulate the T cell arm of the immune system, which is increasingly recognized as critical to generating protective immune responses against a wide array of diseases.
